CASAA Comes Out In Support of PMI’s MRTP Application for IQOS

0
3101

If the FDA approves PMI’s application, it will be able to include the following claims in its marketing of iQOS:

– IQOS system heats tobacco but does not burn it.
– This significantly reduces the production of harmful and potentially harmful chemicals.
– Scientific studies have shown that switching completely from cigarettes to the IQOS system can reduce the risks of tobacco-related diseases.
– Switching completely to IQOS presents less risk of harm than continuing to smoke cigarettes.
– Switching completely from cigarettes to the IQOS system significantly reduces your body’s exposure to harmful and potentially harmful chemicals.

Since the FDA gained regulatory authority over tobacco products in 2009, it has yet to approve any MRTP applications. You can read CASAA’s full comment here.

To read more about PMI’s original application seeking FDA approval to sell its iQOS product, click here.